CrossRef The Antihistamine Astemizole Potentiates the Antitumor Efficacy of Sorafenib in Hepatocellular Carcinoma by Suppressing Proliferation, Metastasis, and Angiogenesis Yixuan Zhang, Xin Chen, Xuting Yang, Peiyu Wang, Xiaoliang Zhang, Dexin Kong, Ran Wang Current Issues in Molecular Biology .2026
Member Notifications Members will receive notices at least 45 days before the effective date
Understanding the D-SNP Opportunity Let's start with the statistics that should make every agent pay attention: 70% of dual-eligibles aren't enrolled in a D-SNP plan yet (KFF) 20% of Medicare Advantage enrollees are in SNPs (with 88% of those in D-SNPs) (KFF) 100% increase in SNP enrollment since 2019 (Justice In Aging) Most D-SNPs include vision, dental, and hearing coverage as standard benefits Why State Program Changes Matter Many states are transitioning from demonstration projects to standard D-SNP offerings, creating significant opportunities for agents who stay informed about industry changes
Your prescriber may also consider pausing treatment, reducing the dose, or slowing the dose escalation schedule to help manage gastrointestinal side effects
This was assessed using growth charts that compare average body weight in children of the same sex and age
